Dr. Reddy's Laboratories (RDY) Revenue & Revenue Breakdown
Dr. Reddy's Laboratories Revenue Highlights
Latest Revenue (Y)
$279.16B
Main Geography (Y)
UNITED STATES
Dr. Reddy's Laboratories Revenue by Period
Dr. Reddy's Laboratories Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $279.16B | 13.54% |
| 2023-03-31 | $245.88B | 14.69% |
| 2022-03-31 | $214.39B | 13.00% |
| 2021-03-31 | $189.72B | 8.66% |
| 2020-03-31 | $174.60B | 13.49% |
| 2019-03-31 | $153.85B | 8.32% |
| 2018-03-31 | $142.03B | 0.87% |
| 2017-03-31 | $140.81B | -8.98% |
| 2016-03-31 | $154.71B | 4.40% |
| 2015-03-31 | $148.19B | 12.12% |
| 2014-03-31 | $132.17B | 13.68% |
| 2013-03-31 | $116.27B | 20.19% |
| 2012-03-31 | $96.74B | 29.51% |
| 2011-03-31 | $74.69B | 6.28% |
| 2010-03-31 | $70.28B | 1.20% |
| 2009-03-31 | $69.44B | 38.87% |
| 2008-03-31 | $50.01B | -23.36% |
| 2007-03-31 | $65.25B | 168.19% |
| 2006-03-31 | $24.33B | 24.95% |
| 2005-03-31 | $19.47B | -3.24% |
| 2004-03-31 | $20.12B | 11.69% |
| 2003-03-31 | $18.02B | 8.51% |
| 2002-03-31 | $16.60B | 51.85% |
| 2001-03-31 | $10.94B | - |
Dr. Reddy's Laboratories generated $279.16B in revenue during NA 2024, up 13.54% compared to the previous quarter, and up 181.45% compared to the same period a year ago.
Dr. Reddy's Laboratories Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $72.15B | 4.86% |
| 2023-09-30 | $68.80B | 2.10% |
| 2023-06-30 | $67.38B | 7.01% |
| 2023-03-31 | $62.97B | -6.99% |
| 2022-12-31 | $67.70B | 7.36% |
| 2022-09-30 | $63.06B | 20.91% |
| 2022-06-30 | $52.15B | -4.07% |
| 2022-03-31 | $54.37B | 2.20% |
| 2021-12-31 | $53.20B | -7.70% |
| 2021-09-30 | $57.63B | 17.15% |
| 2021-06-30 | $49.19B | 4.04% |
| 2021-03-31 | $47.28B | -4.08% |
| 2020-12-31 | $49.30B | 0.67% |
| 2020-09-30 | $48.97B | 10.85% |
| 2020-06-30 | $44.17B | -0.32% |
| 2020-03-31 | $44.32B | 1.09% |
| 2019-12-31 | $43.84B | -8.69% |
| 2019-09-30 | $48.01B | 24.91% |
| 2019-06-30 | $38.44B | -4.31% |
| 2019-03-31 | $40.17B | 4.33% |
| 2018-12-31 | $38.50B | 1.37% |
| 2018-09-30 | $37.98B | 2.07% |
| 2018-06-30 | $37.21B | 5.26% |
| 2018-03-31 | $35.35B | -7.12% |
| 2017-12-31 | $38.06B | 7.33% |
| 2017-09-30 | $35.46B | 6.94% |
| 2017-06-30 | $33.16B | -6.70% |
| 2017-03-31 | $35.54B | -4.11% |
| 2016-12-31 | $37.06B | 3.37% |
| 2016-09-30 | $35.86B | 10.86% |
| 2016-06-30 | $32.34B | -13.89% |
| 2016-03-31 | $37.56B | -5.34% |
| 2015-12-31 | $39.68B | -0.53% |
| 2015-09-30 | $39.89B | 6.15% |
| 2015-06-30 | $37.58B | -2.91% |
| 2015-03-31 | $38.70B | 0.71% |
| 2014-12-31 | $38.43B | 7.11% |
| 2014-09-30 | $35.88B | 2.00% |
| 2014-06-30 | $35.17B | 1.05% |
| 2014-03-31 | $34.81B | -1.50% |
| 2013-12-31 | $35.34B | 5.25% |
| 2013-09-30 | $33.58B | 18.02% |
| 2013-06-30 | $28.45B | -14.82% |
| 2013-03-31 | $33.40B | 16.58% |
| 2012-12-31 | $28.65B | -0.55% |
| 2012-09-30 | $28.81B | 13.39% |
| 2012-06-30 | $25.41B | 28.42% |
| 2012-03-31 | $19.78B | -28.56% |
| 2011-12-31 | $27.69B | 22.11% |
| 2011-09-30 | $22.68B | 14.63% |
| 2011-06-30 | $19.78B | -1.93% |
| 2011-03-31 | $20.17B | 6.26% |
| 2010-12-31 | $18.98B | 1.50% |
| 2010-09-30 | $18.70B | 11.13% |
| 2010-06-30 | $16.83B | 2.48% |
| 2010-03-31 | $16.42B | -5.05% |
| 2009-12-31 | $17.30B | -5.84% |
| 2009-09-30 | $18.37B | 0.98% |
| 2009-06-30 | $18.19B | -8.37% |
| 2009-03-31 | $19.85B | 7.88% |
| 2008-12-31 | $18.40B | 13.93% |
| 2008-09-30 | $16.15B | 7.40% |
| 2008-06-30 | $15.04B | 13.76% |
| 2008-03-31 | $13.22B | - |
Dr. Reddy's Laboratories generated - in revenue during Q4 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Dr. Reddy's Laboratories Revenue Breakdown
Dr. Reddy's Laboratories Revenue Breakdown by Country
Annual Revenue by Country
| Country | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| Russia Country | $22.30B | $21.23B | $20.88B | $15.82B | $16.90B |
| UNITED STATES | $135.56B | - | - | - | - |
| Others Countries Country | $72.83B | $67.47B | $68.96B | $60.95B | $49.58B |
| India Country | $48.47B | $50.50B | $43.99B | $36.25B | $32.09B |
Latest
Dr. Reddy's Laboratories's latest annual revenue breakdown by geography, as of Mar 24: UNITED STATES (48.56%), Others Countries Country (26.09%), India Country (17.36%), and Russia Country (7.99%).
Dr. Reddy's Laboratories Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| RDY | Dr. Reddy's Laboratories | $279.16B | - |
| ALKS | Alkermes | $1.66B | $378.14M |
| PBH | Prestige Consumer Healthcare | $1.13B | $283.55M |
| PAHC | Phibro Animal Health | $977.89M | $273.16M |
| EVO | Evotec SE | $781.43M | $208.73M |
| PCRX | Pacira BioSciences | $674.98M | $168.57M |
| SUPN | Supernus Pharmaceuticals | $607.52M | $175.69M |
| COLL | Collegium Pharmaceutical | $566.77M | $159.30M |
| ANIP | ANI Pharmaceuticals | $486.82M | $148.33M |
| ITCI | Intra-Cellular Therapies | $462.18M | $175.38M |